The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy-Potential Implications in the Treatment of Osteogenesis Imperfecta

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Oct 26

PMID 39458939

Authors

Qingling Guo

Qiming Zhai

Ping Ji

Affiliations

Soon will be listed here.

Abstract

Osteogenesis imperfecta (OI) is a hereditary disorder characterized by bones that are fragile and prone to breaking. The efficacy of existing therapies for OI is limited, and they are associated with potentially harmful side effects. OI is primarily due to a mutation of collagen type I and hence impairs bone regeneration. Mesenchymal stem cell (MSC) therapy is an attractive strategy to take advantage of the potential benefits of these multipotent stem cells to address the underlying molecular defects of OI by differentiating osteoblasts, paracrine effects, or immunomodulation. The maintenance of mitochondrial homeostasis is an essential component for improving the curative efficacy of MSCs in OI by affecting the differentiation, signaling, and immunomodulatory functions of MSCs. In this review, we highlight the MSC-based therapy pathway in OI and introduce the MSC regulation mechanism by mitochondrial homeostasis. Strategies aiming to modulate the metabolism and reduce the oxidative stress, as well as innovative strategies based on the use of compounds (resveratrol, NAD+, α-KG), antioxidants, and nanomaterials, are analyzed. These findings may enable the development of new strategies for the treatment of OI, ultimately resulting in improved patient outcomes.

References

Yadav N, Patel V, McCourt L, Ruppert M, Miller M, Inerbaev T . Tuning the enzyme-like activities of cerium oxide nanoparticles using a triethyl phosphite ligand. Biomater Sci. 2022; 10(12):3245-3258. DOI: 10.1039/d2bm00396a. View

Chang C, Yan J, Yao Z, Zhang C, Li X, Mao H . Effects of Mesenchymal Stem Cell-Derived Paracrine Signals and Their Delivery Strategies. Adv Healthc Mater. 2021; 10(7):e2001689. PMC: 7995150. DOI: 10.1002/adhm.202001689. View

Li J, Deng C, Liang W, Kang F, Bai Y, Ma B . Mn-containing bioceramics inhibit osteoclastogenesis and promote osteoporotic bone regeneration via scavenging ROS. Bioact Mater. 2021; 6(11):3839-3850. PMC: 8050801. DOI: 10.1016/j.bioactmat.2021.03.039. View

Li Q, Cheng J, Jiang Q, Lee W . Role of sirtuins in bone biology: Potential implications for novel therapeutic strategies for osteoporosis. Aging Cell. 2021; 20(2):e13301. PMC: 7884050. DOI: 10.1111/acel.13301. View

Deng Z, Wang W, Xu X, Nie Y, Liu Y, Gould O . Biofunction of Polydopamine Coating in Stem Cell Culture. ACS Appl Mater Interfaces. 2021; 13(9):10748-10759. DOI: 10.1021/acsami.0c22565. View

Lee J, Jung H, Han Y, Yoon Y, Yun C, Sun H . Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells. Mol Med Rep. 2016; 14(4):3777-84. PMC: 5042755. DOI: 10.3892/mmr.2016.5706. View

Mendt M, Kamerkar S, Sugimoto H, McAndrews K, Wu C, Gagea M . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018; 3(8). PMC: 5931131. DOI: 10.1172/jci.insight.99263. View

Etich J, Lessmeier L, Rehberg M, Sill H, Zaucke F, Netzer C . Osteogenesis imperfecta-pathophysiology and therapeutic options. Mol Cell Pediatr. 2020; 7(1):9. PMC: 7427672. DOI: 10.1186/s40348-020-00101-9. View

Crewe C, Funcke J, Li S, Joffin N, Gliniak C, Ghaben A . Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab. 2021; 33(9):1853-1868.e11. PMC: 8429176. DOI: 10.1016/j.cmet.2021.08.002. View

10.

Choi Y, Yoon D, Lee K, Choi S, Lee M, Park K . Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation. Aging Dis. 2019; 10(4):818-833. PMC: 6675538. DOI: 10.14336/AD.2018.0802. View

11.

Yan C, Shi Y, Yuan L, Lv D, Sun B, Wang J . Mitochondrial quality control and its role in osteoporosis. Front Endocrinol (Lausanne). 2023; 14:1077058. PMC: 9922754. DOI: 10.3389/fendo.2023.1077058. View

12.

Kim H, Ponte F, Warren A, Ring R, Iyer S, Han L . A decrease in NAD contributes to the loss of osteoprogenitors and bone mass with aging. NPJ Aging Mech Dis. 2021; 7(1):8. PMC: 8016898. DOI: 10.1038/s41514-021-00058-7. View

13.

Estevez A, Ganesana M, Trentini J, Olson J, Li G, Boateng Y . Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA. Biomolecules. 2019; 9(10). PMC: 6843313. DOI: 10.3390/biom9100562. View

14.

Dai Z, Li Y, Quarles L, Song T, Pan W, Zhou H . Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007; 14(12):806-14. DOI: 10.1016/j.phymed.2007.04.003. View

15.

Ott S . Long-term safety of bisphosphonates. J Clin Endocrinol Metab. 2005; 90(3):1897-9. DOI: 10.1210/jc.2005-0057. View

16.

Gao J, Feng Z, Wang X, Zeng M, Liu J, Han S . SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 2017; 25(2):229-240. PMC: 5762839. DOI: 10.1038/cdd.2017.144. View

17.

Liu A, Lv Z, Yan Z, Wu X, Yan L, Sun L . Association of mitochondrial homeostasis and dynamic balance with malignant biological behaviors of gastrointestinal cancer. J Transl Med. 2023; 21(1):27. PMC: 9843870. DOI: 10.1186/s12967-023-03878-1. View

18.

Wang Y, Deng P, Liu Y, Wu Y, Chen Y, Guo Y . Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations. Nat Commun. 2020; 11(1):5596. PMC: 7645772. DOI: 10.1038/s41467-020-19360-1. View

19.

Hao T, Li J, Yao F, Dong D, Wang Y, Yang B . Injectable Fullerenol/Alginate Hydrogel for Suppression of Oxidative Stress Damage in Brown Adipose-Derived Stem Cells and Cardiac Repair. ACS Nano. 2017; 11(6):5474-5488. DOI: 10.1021/acsnano.7b00221. View

20.

Watanabe J, Yamada M, Niibe K, Zhang M, Kondo T, Ishibashi M . Preconditioning of bone marrow-derived mesenchymal stem cells with N-acetyl-L-cysteine enhances bone regeneration via reinforced resistance to oxidative stress. Biomaterials. 2018; 185:25-38. DOI: 10.1016/j.biomaterials.2018.08.055. View